Angiogram Based Fractional Flow Reserve FFRangio

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

In the present study we aim at validating the computation of FFRangio values from the angiogram by comparing them to measured wire-based FFR values, in a larger scale and in a completely blinded manner. Investigation of a wide range of users in various conditions may strengthen the reliability of the FFRAngio measurements.

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05442723` - Extensively Diseased Left Anterior Descending Coronary Artery: On Pump vs Off Pump CABG?	N/A

NCT number	NCT03005028
Study type	Observational
Source	CathWorks Ltd.
Contact
Status	Completed
Phase	N/A
Start date	January 2015
Completion date	March 15, 2016

Angiogram Based Fractional Flow Reserve FFRangio - A Validation Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms